ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

IMPOYZ
Psoriasis
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

IMPOYZ Rx

Generic Name and Formulations:
Clobetasol propionate 0.025%; crm.

Company:
Encore Dermatology, Inc.

Therapeutic Use:

RECENT UPDATES

Monograph added.

Indications for IMPOYZ:

Moderate to severe plaque psoriasis.

Adult:

≥18yrs: apply thin layer twice daily; max 50g/week and 2 consecutive weeks' treatment per course. Discontinue when control is achieved. Wash hands after application. Do not occlude.

Children:

<18yrs: not recommended.

Warnings/Precautions:

Avoid use on face, scalp, axilla, groin, or other intertriginous areas. Do not use for diaper dermatitis or on pre-existing skin atrophy. Risk of HPA axis suppression with high-potency steroids, prolonged use, application to large surface area, use of occlusive dressings, altered skin barrier, liver failure, young age; discontinue gradually, reduce dose, or substitute with less potent corticosteroid if occurs. Treat infection if present; discontinue if infection persists or worsens. Avoid abrupt cessation in chronic use. Reevaluate periodically. Pregnancy. Nursing mothers.

Pharmacological Class:

Corticosteroid.

Adverse Reactions:

Application site discoloration, burning, itching, irritation, dryness, folliculitis, acneiform eruptions, hypertrichosis, hypopigmentation, perioral dermatitis, allergic contact dermatitis (discontinue if irritation occurs), secondary infection, striae, miliaria; HPA axis suppression (esp. in children); rare: Cushing's syndrome, hyperglycemia, glucosuria.

Generic Availability:

NO

How Supplied:

Crm—60g

Sign Up for Free e-newsletters